About
Emmessar Biotech & Nutrition Limited, a healthcare company, provides healthcare and nutritional products in India and internationally. The company operates through Healthcare and Rent on Lease Land segments. It also offers CalmCream, a multi-functional skin cream; Calm Cream RESQ, a skin cream used for burns from sun, radiation, heat and chemicals; Cute-N-Comely, a cosmetic skin cream; MagiCream, a cream used for post-surgical scars; and Muscle Flex Gel, a gel used to relieve pain from aching muscles. In addition, the company offers vedaceuticals, an ayurveda disease curing medicine. Further, it provides healthcare products for dermatology, osteoporosis, anti-ageing, physical ailments, and burns, including radiation. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was incorporated in 1992 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap12 Cr
P/E30.50
Div Yield0.00 %
Book Value₹16.20
52w High₹42.80
52w Low₹18.40
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.06 | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.34 | 0.08 | 0.08 | 0.33 | 0.08 | 0.07 |
| Expenses | 0.41 | 0.46 | 0.43 | 0.46 | 0.36 | 0.43 | 0.38 | 0.42 | 0.36 | 0.47 | 0.54 | 0.30 | 0.35 |
| Operating Profit | -0.35 | -0.37 | -0.34 | -0.37 | -0.27 | -0.33 | -0.28 | -0.08 | -0.28 | -0.39 | -0.21 | -0.22 | -0.28 |
| OPM % | -583.33 | -411.11 | -377.78 | -411.11 | -300.00 | -330.00 | -280.00 | -23.53 | -350.00 | -487.50 | -63.64 | -275.00 | -400.00 |
| Other Income | 0.54 | 0.47 | 0.49 | 0.54 | 0.53 | 0.61 | 0.43 | 0.51 | 0.46 | 0.48 | 0.53 | 0.53 | 0.46 |
| Depreciation | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.17 | 0.07 | 0.12 | 0.14 | 0.24 | 0.26 | 0.13 | 0.41 | 0.16 | 0.07 | 0.30 | 0.29 | 0.16 |
| Tax % | 17.65 | 57.14 | 8.33 | 21.43 | 25.00 | 126.92 | 84.62 | 31.71 | 43.75 | -285.71 | 56.67 | 31.03 | 68.75 |
| Net Profit | 0.13 | 0.03 | 0.12 | 0.11 | 0.17 | -0.07 | 0.02 | 0.28 | 0.09 | 0.27 | 0.13 | 0.20 | 0.05 |
| EPS in Rs | 0.26 | 0.06 | 0.24 | 0.22 | 0.34 | -0.14 | 0.04 | 0.56 | 0.18 | 0.54 | 0.26 | 0.40 | 0.10 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.37 | 0.61 | 0.56 | 1.02 | 0.36 | 6.99 | 3.40 | 0.63 | 1.27 | 2.61 | 1.98 | 2.19 |
| Expenses | 1.73 | 1.56 | 1.64 | 1.71 | 1.26 | 6.15 | 3.81 | 1.27 | 1.67 | 2.38 | 2.66 | 2.34 |
| Operating Profit | -1.36 | -0.95 | -1.08 | -0.69 | -0.90 | 0.84 | -0.41 | -0.64 | -0.40 | 0.23 | -0.68 | -0.15 |
| OPM % | -367.57 | -155.74 | -192.86 | -67.65 | -250.00 | 12.02 | -12.06 | -101.59 | -31.50 | 8.81 | -34.34 | -6.85 |
| Other Income | 2.04 | 2.01 | 1.99 | 1.75 | 1.92 | 1.47 | 1.21 | 1.01 | 1.25 | 0.98 | 0.03 | 0.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.06 | 0.06 | 0.08 | 0.05 | 0.01 | 0.03 | 0.07 |
| Profit before tax | 0.58 | 0.96 | 0.81 | 0.97 | 0.93 | 2.25 | 0.74 | 0.29 | 0.80 | 1.19 | -0.68 | -0.16 |
| Tax % | 24.14 | 66.67 | 7.41 | 47.42 | 48.39 | 36.00 | -2.70 | -82.76 | -15.00 | 0.00 | -30.88 | -25.00 |
| Net Profit | 0.44 | 0.32 | 0.75 | 0.50 | 0.48 | 1.45 | 0.75 | 0.53 | 0.91 | 1.19 | -0.47 | -0.12 |
| EPS in Rs | 0.88 | 0.64 | 1.50 | 1.00 | 0.96 | 2.90 | 1.50 | 1.06 | 1.82 | 2.38 | -0.94 | -0.24 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Reserves | 3.12 | 2.71 | 2.41 | 1.67 | 1.17 | 0.70 | -0.73 | -1.49 | -2.01 | -2.91 | -4.09 | -3.62 |
| Borrowings | 0.00 | 0.00 | 0.11 | 0.08 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.41 | 1.51 | 1.23 | 1.19 | 1.04 | 2.11 | 1.86 | 1.59 | 0.92 | 1.13 | 1.36 | 1.03 |
| Total Liabilities | 9.53 | 9.22 | 8.75 | 7.94 | 7.21 | 7.81 | 6.13 | 5.17 | 3.91 | 3.22 | 2.27 | 2.41 |
| Fixed Assets | 1.72 | 1.81 | 1.91 | 2.00 | 2.07 | 1.86 | 1.91 | 1.99 | 2.25 | 0.72 | 0.73 | 1.42 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.80 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets | 7.80 | 7.40 | 6.83 | 5.93 | 5.13 | 5.94 | 4.21 | 3.17 | 1.65 | 1.69 | 1.53 | 0.98 |
| Total Assets | 9.53 | 9.22 | 8.75 | 7.94 | 7.21 | 7.81 | 6.13 | 5.17 | 3.91 | 3.22 | 2.27 | 2.41 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.27 | 0.22 | 0.64 | 0.38 | 2.27 | 0.47 | 1.03 | 0.39 | 0.74 | 0.75 | -0.01 |
| Cash from Investing Activity | -0.26 | -0.23 | -0.64 | -0.55 | -2.61 | 0.01 | -1.06 | -0.37 | -0.69 | -0.74 | 0.00 |
| Cash from Financing Activity | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | 0.02 | 0.00 | 0.00 | -0.17 | -0.34 | 0.48 | -0.03 | 0.01 | 0.05 | 0.01 | -0.01 |
| Free Cash Flow | 0.26 | 0.22 | 0.64 | 0.35 | 1.96 | 0.47 | 1.03 | 0.39 | -0.04 | -0.06 | -0.01 |
| CFO/OP % | -11.00 | -25.00 | -57.00 | -46.00 | -284.00 | 68.00 | -251.00 | -61.00 | -198.00 | 343.00 | 7.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19.73 | 11.97 | 13.04 | 3.58 | 10.14 | 141.51 | 3.22 | 23.17 | 8.62 | 5.59 | 66.36 | 6.67 |
| Inventory Days | 405.56 | 230.53 | 164.25 | 127.75 | 196.54 | 7.24 | 272.56 | 2,049.62 | 52.14 | 121.67 | 136.88 | 335.80 |
| Days Payable | 40.56 | 0.00 | 18.25 | 0.00 | 56.15 | 51.70 | 189.61 | 1,628.46 | 5.79 | 76.04 | 76.04 | 150.87 |
| Cash Conversion Cycle | 384.73 | 242.49 | 159.04 | 131.33 | 150.52 | 97.05 | 86.18 | 444.33 | 54.97 | 51.22 | 127.20 | 191.60 |
| Working Capital Days | 98.65 | 35.90 | 91.25 | 114.51 | -60.83 | 79.37 | 30.06 | 457.70 | 175.31 | 85.31 | 22.12 | 38.33 |
| ROCE % | 7.33 | 12.61 | 11.35 | 15.02 | 15.67 | 45.14 | 25.48 | 17.66 | 31.50 | 80.00 | -39.30 | -10.81 |
Corporate Actions
No corporate actions recorded.